Key points are not available for this paper at this time.
Advances HCM mechanistic models; leaves open whether SRX-targeted therapies improve patient outcomes.
; DCM 26%, p=0.66; controls 20%, p=0.23). HCM variant locations predict impaired IHM formation and stability, and attenuation of the SRX state - accounting for altered contractility, reduced diastolic relaxation, and increased energy consumption, that fully characterizes HCM pathogenesis.
No takes yet. Share an insight, caveat, or question.
Álamo et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: